Literature DB >> 1507256

The prognostic significance of race and survival from laryngeal carcinoma.

M Roach1, M Alexander, J L Coleman.   

Abstract

Surveillance, Epidemiology, and End Results (SEER) program data suggest that blacks with laryngeal carcinoma have a significantly lower 5-year survival rate than whites. Most of this difference persists despite adjustment for "crude stage." To evaluate possible factors contributing to this residual survival deficit, 190 white and 23 black patients treated at the Martinez Veterans Administration Hospital between 1968 and 1988 were studied. The independent impact of race on survival rate was analyzed with respect to various prognostic factors including treatment delay, elapsed time (diagnosis to treatment), age, stage, cancer subsites, and type of therapy. No independent prognostic significance could be attributed to race. The differences noted in SEER data probably reflect a tendency for the use of crude stage to underestimate the impact of prognostic groups within the categories of "local" and "regional" disease, the independent prognostic significance of subsites (glottic versus supraglottic), and the variable distribution of these subsites in different populations. This study suggests that when stage, subsite, and quality of care are adequately considered, survival from laryngeal cancer in blacks is comparable to that of whites.

Entities:  

Mesh:

Year:  1992        PMID: 1507256      PMCID: PMC2571639     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  19 in total

1.  Contribution of socioeconomic status to black/white differences in cancer incidence.

Authors:  W P McWhorter; A G Schatzkin; J W Horm; C C Brown
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

2.  Relation between the race and economic status of patients and who performs their surgery.

Authors:  L D Egbert; I L Rothman
Journal:  N Engl J Med       Date:  1977-07-14       Impact factor: 91.245

3.  Race and socio-economic status in survival from breast cancer.

Authors:  H H Dayal; R N Power; C Chiu
Journal:  J Chronic Dis       Date:  1982

4.  Measuring racial bias in inpatient treatment.

Authors:  J A Flaherty; R Meagher
Journal:  Am J Psychiatry       Date:  1980-06       Impact factor: 18.112

5.  Lack of a significant independent effect of race on survival in breast cancer.

Authors:  R D Dansey; P A Hessel; S Browde; M Lange; D Derman; M Nissenbaum; W R Bezwoda
Journal:  Cancer       Date:  1988-05-01       Impact factor: 6.860

6.  Cancer mortality in a higher-income black population in New York State. Comparison with rates in the United States as a whole.

Authors:  A P Polednak
Journal:  Cancer       Date:  1990-10-01       Impact factor: 6.860

7.  Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer.

Authors:  S W Vernon; B C Tilley; A V Neale; L Steinfeldt
Journal:  Cancer       Date:  1985-04-01       Impact factor: 6.860

8.  Is there a genetic basis for the differences in cancer incidence between Afro-Americans and Euro-Americans?

Authors:  A Goldson; U Henschke; L D Leffall; R L Schneider
Journal:  J Natl Med Assoc       Date:  1981-08       Impact factor: 1.798

9.  Interhospital differences in cancer survival.

Authors:  C J Mettlin; E R Schoenfeld; N Natarajan; O Suh
Journal:  J Chronic Dis       Date:  1987

10.  Prognosis in laryngeal carcinoma: tumour factors.

Authors:  P M Stell
Journal:  Clin Otolaryngol Allied Sci       Date:  1990-02
View more
  4 in total

1.  Acceptability of a Rinse Screening Test for Diagnosing Head and Neck Squamous Cell Carcinoma Among Black Americans.

Authors:  Suzanne C Lechner; Lutécia Pereira; Erika Reategui; Claudia Gordon; Margaret Byrne; Monica Webb Hooper; David J Lee; Marianne Abouyared; Elizabeth Franzmann
Journal:  J Racial Ethn Health Disparities       Date:  2014-09-11

2.  An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas.

Authors:  K M Gorey; E J Holowaty; G Fehringer; E Laukkanen; A Moskowitz; D J Webster; N L Richter
Journal:  Am J Public Health       Date:  1997-07       Impact factor: 9.308

3.  Participation in clinical trials: is it state-of-the-art treatment for African Americans and other people of color?

Authors:  C R Thomas; H A Pinto; M Roach; C B Vaughn
Journal:  J Natl Med Assoc       Date:  1994-03       Impact factor: 1.798

4.  Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care.

Authors:  Leon M Chen; Guojun Li; Lorraine R Reitzel; Kristen B Pytynia; Mark E Zafereo; Qingyi Wei; Erich M Sturgis
Journal:  Cancer Prev Res (Phila)       Date:  2009-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.